Skip to content

Total Revenue at other companies

Pfizer logo
PfizerPFE
$14.45B+5.4%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$24.06B+9.9%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$3.61B+19.0%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$44.21M+168%
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
$116.36M+31.9%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX

Other financials

Income statement

See full
Operating income-$84.2M-13.1%
Net income-$69.2M-5.6%
EPS (diluted)-$0.71+13.4%

Balance sheet

See full
Cash & equivalents$144.1M+60.2%
Total debt$82.2M-6.5%
Total equity$1.5B+95.8%
Total assets$1.7B+81.7%

Cash flow

See full
Operating cash flow-$88.8M-12.2%
CapEx$434.0K-7.1%
Free cash flow-$89.3M-12.1%

Valuation

See full
Market cap$7.44B+283%
Enterprise value$7.38B+280%
P/S144.5×+111×

Profitability

See full
Operating margin-697.7%+635pp
Net margin-612%+602pp
FCF margin-474%+92.4pp

Returns & leverage

See full
Return on equity-27.1%-3.7pp
Debt / equity0.1×-0.1×
Current ratio10.8×+2.3×

Where this comes from

Reported directly by Kymera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kymera Therapeutics's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kymera Therapeutics's total revenue?
Kymera Therapeutics (KYMR) reported total revenue of $34.37M in Q1 2026.
How has Kymera Therapeutics's total revenue changed year-over-year?
Kymera Therapeutics's total revenue increased by 55.5% year-over-year, from $22.1M to $34.37M.
What is the long-term trend for Kymera Therapeutics's total revenue?
Over 4 years (2021 to 2025), Kymera Therapeutics's total revenue has grown at a -14.3% compound annual growth rate (CAGR), from $72.83M to $39.21M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.